The Role of the 21-Gene Recurrence Score in Breast Cancer Treatment.

about

Clinical Application of Detecting 21-Gene Recurrence Score in Predicating Prognosis and Therapy Response of Patients with Breast Cancer from Two Medical Centers.

P2860

Q48110842-405B1BEA-09C9-4680-9F29-8C0F815BE81C

P2860

The Role of the 21-Gene Recurrence Score in Breast Cancer Treatment.

Item

http://www.wikidata.org/entity/Q38846639

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

The Role of the 21-Gene Recurrence Score in Breast Cancer Treatment.

@en

type

Item

label

The Role of the 21-Gene Recurrence Score in Breast Cancer Treatment.

@en

prefLabel

The Role of the 21-Gene Recurrence Score in Breast Cancer Treatment.

@en

P1476

The Role of the 21-Gene Recurrence Score in Breast Cancer Treatment.

@en

P2093

Josee-Lyne Ethier

http://www.w3.org/2001/XMLSchema#string

P2860

Multigene assays and molecular markers in breast cancer: systematic review of health economic analyses

A gene-expression signature as a predictor of survival in breast cancer

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer

Relationship between plasma estradiol levels and estrogen-responsive gene expression in estrogen receptor-positive breast cancer in postmenopausal women.

Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer.

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.

Population-based validation of the prognostic model ADJUVANT! for early breast cancer.

P2888

s40291-016-0209-0

P304

307-313

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40291-016-0209-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Eitan Amir

P577

2016-05-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1037170845

http://www.w3.org/2001/XMLSchema#string

P698

27235162

http://www.w3.org/2001/XMLSchema#string

The Role of the 21-Gene Recurrence Score in Breast Cancer Treatment.

about

P2860

P2860

The Role of the 21-Gene Recurrence Score in Breast Cancer Treatment.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698